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Neisseria gonorrhoeae, the etiologic agent of gonorrhea, is frequently asymptomatic in women, often leading
to chronic infections. One factor contributing to this may be biofilm formation. N. gonorrhoeae can form
biofilms on glass and plastic surfaces. There is also evidence that biofilm formation may occur during natural
cervical infection. To further study the mechanism of gonococcal biofilm formation, we compared transcrip-
tional profiles of N. gonorrhoeae biofilms to planktonic profiles. Biofilm RNA was extracted from N. gonorrhoeae
1291 grown for 48 h in continuous-flow chambers over glass. Planktonic RNA was extracted from the biofilm
runoff. In comparing biofilm with planktonic growth, 3.8% of the genome was differentially regulated. Genes
that were highly upregulated in biofilms included aniA, norB, and ccp. These genes encode enzymes that are
central to anaerobic respiratory metabolism and stress tolerance. Downregulated genes included members of
the nuo gene cluster, which encodes the proton-translocating NADH dehydrogenase. Furthermore, it was
observed that aniA, ccp, and norB insertional mutants were attenuated for biofilm formation on glass and
transformed human cervical epithelial cells. These data suggest that biofilm formation by the gonococcus may
represent a response that is linked to the control of nitric oxide steady-state levels during infection of cervical
epithelial cells.
Neisseria gonorrhoeae is the etiologic agent of gonorrhea, the
second most commonly reported notifiable disease in the
United States today (8). On average, 62 million new cases of
gonorrhea are reported annually worldwide (24). Individuals
infected with gonorrhea are at higher risk for contracting hu-
man immunodeficiency virus (HIV) (8, 22), as the presence of
the gonococcus in the reproductive tract has been shown to
increase local expression of HIV viral RNA (10). In addition,
women are susceptible to chronic complications from undiag-
nosed gonorrhea infection, which is associated with the lack of
noticeable symptoms in most women (30–32). Women infected
with N. gonorrhoeae frequently develop upper genital tract
infection, which leads to pelvic inflammatory disease in up to
45% of women with asymptomatic infection (31).
Antibiotic resistance in N. gonorrhoeae is an increasing prob-
lem in the treatment of gonococcal infection (7, 8, 30, 32, 63).
Control strategies for gonococcal infection have traditionally
relied on single-dose therapy to promptly clear infection and
prevent transmission to others. However, antimicrobial resis-
tance has often compromised these strategies (63). Attempts
to design an effective vaccine for the prevention of gonococcal
infection have been universally unsuccessful (30). In 2006, the
number of cases of gonorrhea in the United States increased
for the second consecutive year (8). Thus, it is becoming in-
creasingly important to identify new strategies for treatment of
this disease.
Many illnesses and infections in humans are exacerbated
and/or caused by biofilms, including dental caries, otitis media,
osteomyelitis, native valve endocarditis, and a number of nos-
ocomial infections (13). N. gonorrhoeae is among those organ-
isms that have recently been investigated for the ability to form
biofilms. N. gonorrhoeae forms structures consistent with bio-
films on abiotic surfaces (glass coverslips) under conditions of
continuous fluid flow and over primary urethral and cervical
epithelial cells under static culture conditions. These structures
contain water channels and a continuous matrix, consistent
with classically observed biofilm structures (25). Results from
our laboratory indicate that N. gonorrhoeae also forms biofilms
over human papillomavirus E6/E7-transformed human cervi-
cal epithelial cells (THCEC) under continuous-flow condi-
tions, while biopsy evidence from patients with culture-proven
gonorrhea indicates that biofilms are present during cervical
infection (59). Altogether, these observations suggest that N.
gonorrhoeae forms biofilm during natural cervical infection in
women, which may contribute to persistent infection and could
be associated with the apparent absence of symptoms in
women.
Although the ability of N. gonorrhoeae to form biofilms has
been established, little is currently known about the mecha-
nism of biofilm formation or the signals that regulate biofilm
production, architecture, and dispersal. Thus, we elected to
compare the transcriptional profiles of N. gonorrhoeae biofilms
to those of planktonic modes of growth in order to identify
genetic pathways involved in biofilm formation and mainte-
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nance. We found that when biofilm growth was compared to
planktonic growth, 3.8% of the genome was differentially reg-
ulated. Our study provides new insights into gonococcal me-
tabolism during the interaction of the gonococcus with human
epithelial cells.
MATERIALS AND METHODS
Bacteria. N. gonorrhoeae strain 1291, a piliated clinical isolate that expresses
Opa proteins, was used in this study. This strain was reconstituted from frozen
stock cultures and propagated at 37°C with 5% CO2 on GC agar (Becton
Dickinson, Franklin Lakes, NJ) supplemented with 1% IsoVitaleX (Becton
Dickinson).
RNA isolation. Overnight plate cultures were used to create cell suspensions of
wild-type N. gonorrhoeae 1291 for inoculation of biofilm flow chambers. N.
gonorrhoeae was grown in continuous-flow chambers in 1:10 GC broth (37)
diluted in phosphate-buffered saline with 1% IsoVitaleX and 100 M sodium
nitrite. Nitrite was added to the biofilm medium, as biofilm formation is signif-
icantly enhanced by the addition of nitrite, allowing mature biofilms to form after
48 h of growth, although nitrite is not required for biofilm formation. Subse-
quently, nitrite was added to all biofilm media, unless otherwise noted. Cell
suspensions (in biofilm medium) of 2  108 CFU/ml were used to inoculate 37-
by 5- by 5-mm (approximately 1-ml volume) flow cell chamber wells. These
chambers were designed to reduce fluid sheer on biofilms (versus that in typical
1-mm-deep wells). Flow chambers were incubated under static conditions at
37°C for 1 h postinoculation. Chambers were then incubated for another 48 h at
a flow rate of 150 l/min. For the first 24 h of biofilm growth, the effluent was
passed through a sterile glass wool filter for the removal of detached biofilm
flocs, collected in a sterile waste flask, and cultured to assess culture purity. At
this time, the waste flask was replaced with a second sterile flask containing 10 ml
of RNAlater (Qiagen Corporation, Valencia, CA) and 100 l of 10% sodium
azide. For the final 24 h of biofilm growth, the filtered planktonic effluent was
collected in this solution to preserve the RNA and to prevent transcriptional
changes from occurring. Planktonic RNA was extracted from the collected ef-
fluent, and biofilm RNA was extracted directly from the biofilm chamber. Two
flow chambers were filtered into a single planktonic collection flask, and each
biofilm RNA sample was extracted from these two flow chambers, while each
planktonic RNA sample was extracted from the combined effluent of these two
flow cells. RNA was extracted using hot acid phenol extraction as follows.
Samples were treated with 1 volume of acid phenol (prepared by adding an equal
volume of 2 M citric acid, pH 4.3, to crystalline phenol and equilibrating it at
room temperature for 24 h) with 0.1% RNase-free sodium dodecyl sulfate,
shaken vigorously, and incubated in a water bath at 80°C for 10 min, with
periodic shaking. The samples were cooled in an ice water bath until cold and
then spun at 7,000 rpm for 20 min at 4°C. The supernatant was removed and
extracted with 1 volume of phenol-chloroform (5:1; Ambion/Applied Biosystems,
Austin, TX) and centrifuged for 15 min. The supernatant was then treated with
1 volume of chloroform and centrifuged for another 15 min. The supernatant was
precipitated with 1 volume of isopropanol with 0.3 M sodium acetate overnight
at 20°C. The RNA was pelleted and washed with 80% ethanol, and the pellet
was dried at room temperature. The RNA was then digested with DNase I (New
England Biolabs, Boston, MA) for 2 h at 37°C and purified using a Qiagen
RNeasy MinElute kit. RNA purity was assessed on an Agilent 2100 bioanalyzer
(Quantum Analytics, Foster City, CA), and only samples with RNA integrity
numbers of 7.5 or greater were used for hybridization to microarrays.
Microarray analysis. A total of two biofilm and two planktonic RNA samples
were hybridized to custom MPAUT1a520274F Affymetrix microarrays (Af-
fymetrix Inc., Santa Clara, CA). These RNAs were transcribed into labeled
target cRNAs as described in the Affymetrix GeneChip manual and were hy-
bridized to the MPAUT1a520274F arrays. Following hybridization, the chips
were stained, scanned, and analyzed by Affymetrix GeneChip operating software
as described by Affymetrix. ArrayAssist 5.5.1 software (Stratagene, an Agilent
Technologies Company, La Jolla, CA) was used to identify significantly differ-
entially regulated genes. All chips were normalized using the RMA algorithm. In
comparing the mean log2 ratios for biofilm versus planktonic samples, genes with
absolute changes of 2.0-fold or greater and P values of 0.05 or less were identified
as differentially regulated.
Quantitative real-time PCR. Array results were validated using SYBR green
quantitative real-time PCR (qRT-PCR). For each target, qRT-PCR primer sets
(Table 1) were selected using Primer Express software (Agilent Technologies)
and obtained from Integrated DNA Technologies (Coralville, IA). RNA samples
were converted into cDNAs as follows. Two microliters of random hexamer
primers (Invitrogen Corp., Carlsbad, CA) was added to 2 g total RNA in a total
volume of 12 l and incubated at room temperature for 10 min to allow primers
to anneal and then transitioned to 70°C to relax RNA secondary structure and
finally cooled on ice for 2 min. Next, 2 l 0.1 M dithiothreitol, 4 l SuperScript
II 10 reaction buffer, 1 l of a mixture containing a 10 mM concentration of
each deoxynucleoside triphosphate, and 1 l SuperScript II were added to each
tube (all reagents were obtained from Invitrogen Corp.) and incubated at 42°C
for 4 h. At this point, RNA was degraded with 3.5 l of 0.5 M EDTA at 65°C for
15 min, and reactions were neutralized with 5 l 1 M Tris and 21.5 l Tris-EDTA
(all reagents were obtained from Ambion/Applied Biosystems). cDNAs were
purified using a Qiagen PCR cleanup kit, quantitated, diluted to 10 ng/l, and
used as templates for qRT-PCR. Relative RNA quantities were determined with
a standard curve (fivefold dilutions of purified genomic DNA ranging from 100
ng/l to 0.00032 ng/l), and all values were normalized to the amount of outer
membrane protein 3 (OMP3) RNA in each sample. Fifty-microliter reaction
mixtures were set up in triplicate and contained 1 SYBR Green master mix
(Ambion/Applied Biosystems) with 3.5 mM magnesium chloride, 10 ng of tem-
plate or genomic DNA standard, and a 1 M final concentration of each primer.
RT-PCR was performed on an ABI Prism 7000 sequence detection system
(Quantum Analytics). Each RT-PCR assay was performed a minimum of two
times, and genes were considered validated if results were consistent for both
assays and absolute changes were equivalent to or greater than the correspond-
ing array changes.
Mutant construction. An insertion mutant construct of the aniA gene was
made via introduction of a kanamycin resistance cassette (pUC4Kan; Amersham
TABLE 1. Primers used in this study
Primera Target Sequence (5–3)
qRT-PCR
primers
MFRTF8 omp3 CGTCGGCATCGCTTTTG
MFRTR8 omp3 CAGGCTGTTCATGCGGTAGTC
MFRTF27 secD ACCAACCGACAAGCCATCAT
MFRTR27 secD CAATCGACCGCGACTATCCT
MFRTF28 aniA CAATCGACCGCGACTATCCT
MFRTR28 aniA GGTTTTTTCGACGGTTTCCA
MFRTF29 ccp GCGCAAGGTGTATTCCAACCT
MFRTR29 ccp AACGGACGGATTTTCTGCAT
MFRTF30 fimT GACAAAAACGGCAATAAGGAATATG
MFRTR30 fimT CGCTGCGGAGGAAAACAT
MFRTF31 nifU TTCCGCCATCGCTTCGT
MFRTR31 nifU TCATCCAGACTTTTGCCTTTG
MFRTF32 nuoF GCATTGCTTGAATCGTTGGAA
MFRTR32 nuoF GGGAACGGCGGTTTGAA
MFRTF33 opaB CAACCGCTCCAGGCAAAA
MFRTR33 opaB TGCGTACGGATGTTTCTGAAAT
MFRTF35 tatC AGACCCTGCTTGCCATTCC
MFRTR35 tatC AGCGTCCGAACCAAATGC
MFRTF36 ngo0023 TTGAGCCCGATTGCGAAT
MFRTR36 ngo0023 CCGCCGGTAATGACAAACTG
MFRTF37 modA13 CGAGCAAGGCGGTATCTCAA
MFRTR37 modA13 GGAAAGTTCGGCATAAACAAACTC
MFRTF38 norB CGAAAGCATCCTGCCTTACTATC
MFRTR38 norB GCGGGTGGTTTGCAACTT
MFRTF39 secF GCAGGGTGCGGATGTCA
MFRTR39 secF CACCCATTTTCAGCGTATCGA
MFRTF40 tatB TTTGGGCGAGCTGATTTTTG
MFRTR40 tatB GGCGTTCTGGACCAAGGA
MFRTF41 narP CCGCAGCAGGCAGTCATT
MFRTR41 narP CGGTAAGGTCGTCGCTGTCT
MFRTF42 narQ TGCAGGAGCGTGCCAAA
MFRTR42 narQ TTGTGCTTGGGAACGGATTT
MFRTF43 mucD GCCGGTATGGGCAGTATCAA
MFRTR43 mucD CCGATGAGTTTGGCGGTATATT
Cloning primers
aniA_F ATGAAACGCCAAGCCTTAG
aniA_R TAAACGCTTTTTTCGGATGCAG
aniA_5Xho1F ACCGCTCGAGGCCGTACTTCCACATTCA
aniA_5Xho1R TGAATGTGGAAGTACGGCCTCGAGCGGT
aniA_upstm AACTACCCTGCCTTTGCCTGATT
aniA_downstm CCGAGGAAAAATAACCGGACATAC
NorBF CAGAGCAGGCAAAGGCAG
NorBRev GAACAGCCCTACCGCATC
a An F as the last letter of the name denotes a forward primer, while an R
denotes a reverse primer. For the cloning primers, the primer name denotes the
target.
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Biosciences, Piscataway, NJ) into a suitable unique restriction site in the coding
region of the aniA gene. The aniA gene from N. gonorrhoeae strain 1291 was
amplified in two fragments, A and B, using primer set A (aniA_F and
aniA5XhoI_R) and primer set B (aniA_R and aniA5XhoI_F), which contains
the restriction site XhoI. The aniA gene containing the XhoI site (at bp 454 in the
coding region) was amplified using fragments A and B and the primers aniA_F
and aniA_R and then cloned into pGEM-T Easy (Promega, Madison, WI),
generating pGEM-aniA(XhoI). The aniA insertional mutations were created by
digesting pGEM-aniA(XhoI) with XhoI and ligating it with the isolated SalI
kanamycin resistance cassette-containing fragment derived from pUC4Kan. The
mutant construct was linearized with SacII, and N. gonorrhoeae strain 1291 was
transformed with aniA::kan as described previously (36). Multiple independent
mutant strains were isolated and confirmed by sequencing and PCR, using the
primers aniA_upstm and aniA_downstm. An insertion mutant construct of the
norB gene was also made via introduction of the kanamycin resistance cassette
from pUC4Kan (Amersham) into a suitable unique restriction site in the coding
region of the norB gene. The norB gene from N. gonorrhoeae strain 1291 was
amplified using primers NorBF and NorBRev, and the resulting product was
cloned into pGEM-T Easy (Promega). The norB insertional mutation was cre-
ated by digesting this plasmid with BsaBI and ligating it with the isolated HincII
kanamycin resistance cassette-containing fragment derived from pUC4Kan (Am-
ersham). The mutant construct was linearized with NotI and transformed into N.
gonorrhoeae strain 1291 as described previously (36). For each mutant construct,
multiple independent mutant strains were isolated and confirmed by sequencing
and PCR, using the same primers. See Table 1 for cloning primers and Table 2
for plasmids and strains.
Biofilm growth in continuous-flow chambers over glass. Wild-type N. gonor-
rhoeae strain 1291 and aniA::kan, ccp::kan, and norB::kan insertional mutants
were assayed for the ability to form biofilms. A ccp::kan mutant was described in
an earlier publication (53) and was transformed with pGFP for examination of
biofilms via confocal microscopy. Strains were propagated from frozen stock
cultures on GC agar with 1% IsoVitaleX (Becton Dickinson, Franklin Lakes, NJ)
and incubated at 37°C and 5% CO2. Overnight plate cultures were used to create
cell suspensions for inoculation of biofilm flow chambers. N. gonorrhoeae was
grown in continuous-flow chambers over glass as described previously. Chloram-
phenicol was added to the medium at a final concentration of 5 g/l to maintain
pGFP. After 48 h, the biofilm effluent was cultured to assure culture purity, and
biofilm formation was assessed via confocal microscopy.
Growth curves under oxygen tension conditions present in biofilm medium. A
GEM Premier 3000 blood gas meter (Instrumentation Laboratory Company,
Bedford, MA) was used to measure the dissolved oxygen content present in the
biofilm medium collected from the medium reservoir and the biofilm outflow at
0, 24, and 48 h of biofilm growth. The medium was collected under mineral oil
to prevent gas exchange during collection. Approximately 0.2 ml of each sample
was run on the blood gas meter immediately following collection. Static growth
curves for N. gonorrhoeae aniA::kan, ccp::kan, and norB::kan mutants and the
wild-type parent strain were then performed under similar oxygen tension con-
ditions in GC broth with 1% IsoVitalex and 100 M sodium nitrite and assessed
by measuring the dissolved oxygen content of the culture medium. Growth was
monitored for 48 h.
THCEC culture. Primary cervical cells were obtained from cervical biopsies
performed at the University of Iowa Hospitals and Clinics, Iowa City, IA, and
immortalized by the methodology developed by Klingelhutz et al. (38). The
resulting cell line was designated THCEC. Our studies have confirmed the
presence of complement receptor type III on the surfaces of these transformed
cells and their ability to secrete complement components. These factors are
important in gonococcal attachment to and invasion of cervical epithelial cells
(18). THCEC were cultured in 100-mm tissue culture plates in serum-free ke-
ratinocyte growth medium (K-SFM) supplemented with 12.5 mg bovine pituitary
extract, 0.08 g epidermal growth factor per 500-ml bottle, and a final concen-
tration of 1% penicillin-streptomycin (Gibco Cell Culture) at 37°C and 5% CO2.
Once confluent, the cells were split onto collagen-coated coverslips, which were
prepared by autoclaving 22- by 50-mm no. 1 coverslips in bovine tendon collagen
type I (Worthington Biochemical Corp., Lakewood, NY), removing the cover-
slips from solution, and allowing them to dry for 30 min in 100-mm tissue culture
plates at room temperature. Cells were split as follows. Two milliliters of 0.25%
tryspin–1 mM EDTA (Gibco) was applied to a confluent 100-mm tissue culture
plate for 4 min at room temperature and then aspirated, and the plate was
incubated for an additional 5 min at 37°C and 5% CO2. Cells were collected in
5 ml K-SFM with 5% fetal bovine serum (Gibco) to neutralize trypsin-EDTA
and then spun down and resuspended in a final volume of K-SFM to result in a
1:8 dilution per glass coverslip. A total of 0.5 ml of this cell suspension was
applied to each collagen-coated coverslip, covering the entire surface. Coverslips
were then incubated for 3 to 4 h at 37°C and 5% CO2 to allow cells to adhere,
and then plates were flooded with K-SFM (10 ml). Cells were grown until
confluent at 37°C and 5% CO2 (2 days) and were stained with Cell Tracker
Orange (Molecular Probes) just prior to infection.
Biofilm growth in continuous-flow chambers over cells. N. gonorrhoeae was
grown in continuous-flow chambers adapted for tissue culture in 1:5 JEM me-
dium (2 parts serum-free hybridoma medium, 1 part McCoy’s 5A medium, and
1 part defined K-SFM; all available from Gibco) diluted in phosphate-buffered
saline with 1% IsoVitaleX, 100 M sodium nitrite, 0.5 g/liter sodium bicarbonate
to buffer the medium, and 5 g/l chloramphenicol to maintain pGFP. Fifty- by
22- by 5-mm tissue culture biofilm chambers (approximately 3-ml volume) were
assembled with confluent THCEC coverslips, which were placed between the top
and bottom portions of the chamber, which was then sealed using a rubber gasket
and screws that fasten the top and bottom portions together. Chambers were
inoculated at a multiplicity of infection (MOI) of 100:1, using cell suspensions
prepared in biofilm medium. Flow chambers were incubated under static condi-
tions at 37°C and 5% CO2 for 1 h postinfection to allow attachment to THCEC.
Chambers were then incubated for 48 h at 37°C under flow at 180 l/min. After
48 h, the biofilm effluent was cultured to assure culture purity, and biofilm
formation was assessed via confocal microscopy.
Confocal microscopy of continuous-flow chambers. z-Series photomicrographs
of flow chamber biofilms were taken with a Nikon PCM-2000 confocal micro-
scope scanning system (Nikon, Melville, NY), using a modified stage for flow cell
microscopy. Green fluorescent protein (GFP) was excited at 450 to 490 nm for
biofilm imaging. Three-dimensional images of the biofilms were created from
each z series, using Volocity high-performance three-dimensional imaging soft-
ware (Improvision Inc., Lexington, MA). The images were adjusted to incorpo-
rate the pixel sizes for the x, y, and z axes of each image stack.
COMSTAT analysis of confocal z series. Quantitative analysis of each z series was
performed using COMSTAT (28), available from http://www.im.dtu.dk/comstat/.
COMSTAT is a mathematical script written for MATLAB 5.3 (The Mathworks,
Inc., Natick, MA) that quantifies three-dimensional biofilm structures by evalu-
ating confocal image stacks so that pixels may be converted to relevant measure-
ments of biofilm, including total biomass and average thickness. To complete
COMSTAT analysis, an information file was created for each z series to adjust
for the pixel sizes of the x, y, and z axes and the number of images in each z series.
COMSTAT was then used to obtain threshold images to reduce the background.
Biomass and the average and maximum thicknesses in each z series were calcu-
lated by COMSTAT, using the threshold images.
Treatment of biofilms with nitric oxide donor and inhibitor. N. gonorrhoeae
1291 wild-type biofilms were treated with the nitric oxide donor sodium nitro-
prusside (SNP), either at the start of the biofilm or after 24 h of biofilm forma-
tion. When treating cells at the start of the biofilm, a final concentration of 500
nM SNP was added to the biofilm medium prior to initiating flow, and this
medium was used to create suspensions for inoculation of the biofilm. When
treating cells after 24 h of biofilm formation, a final concentration of 500 nM SNP
was added to the medium reservoir after the biofilm had been allowed 24 h of
growth time. To demonstrate that the effects of SNP were due to nitric oxide
release, wild-type biofilms were also treated with the nitric oxide quencher
2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide (PTIO). These biofilms
were treated at the start of the biofilm with final concentrations of 500 nM SNP
and 1 M PTIO. All treated samples and untreated controls were run in qua-
druplicate for a minimum of four experiments. N. gonorrhoeae 1291 norB::kan
TABLE 2. Strains and plasmids used in this study
Strain or plasmid Relevant genotypeor properties
Source or
reference
Strains
N. gonorrhoeae 1291 Wild type
aniA::kan mutant aniA::kan aniA This study
norB::kan mutant norB::kan norB This study
ccp::kan mutant ccp::kan ccp 53
Plasmids
pGEM-T Easy Promega
pUC4Kan pUC4; Kanr Amersham
Biosciences
pGEM-aniA(XhoI) pGEM-T Easy/aniA This study
pGEM-aniA::kan pGEM-T Easy/aniA::kan aniA This study
pGEM-norB pGEM-T Easy/norB This study
pGEM-norB::kan pGEM-T Easy/norB::kan norB This study
pGFP pLES98/GFP; Chlr 17
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mutant biofilms were also treated with PTIO (0.1 mM) and compared to un-
treated norB::kan mutant biofilms, which were run at the same time. Biofilm
formation was evaluated by confocal microscopy and COMSTAT analysis as
previously described.
Statistical analysis of COMSTAT results. Statistical analysis was performed
with Prism 4 software (GraphPad Software, Inc., La Jolla, CA). Paired t tests and
nonparametric one-way analysis of variance with Dunn’s multiple comparison
posttest were used to compare the biomass, average thickness, and maximum
thickness of aniA::kan, ccp::kan, and norB::kan insertional mutant biofilms to
those of the wild-type biofilm or treated samples to the 48-h untreated biofilm
sample for the NO studies. Values that met a P value cutoff of 0.05 were
considered statistically different.
RESULTS
Microarray analysis of genes differentially expressed during
growth as a biofilm. Our working hypothesis was that physio-
logical differences between biofilm and planktonic cells would
be reflected in their transcriptional profiles. We compared the
transcriptional profiles of cells grown as a biofilm to those of
planktonic cells collected from the biofilm outflow, allowing
for the identification of gene expression patterns that are spe-
cific to biofilm growth and development. Genes with an abso-
lute change of 2.0-fold or greater and a P value of 0.05 or less
were identified as differentially regulated. Under these analysis
conditions, 83 genes were identified as differentially regulated,
comparing biofilm to planktonic growth (see Tables S1 and S2
in the supplemental material). This represents approximately
3.8% of the genome.
Forty-eight hypothetical genes were identified, which ac-
counts for 57.8% of the differentially regulated genes. How-
ever, the majority of the upregulated genes (11 of 16 genes) do
have identified functions. Five of these genes had changes that
were 2.5-fold, including three genes, aniA, ccp, and norB,
which play critical roles in the anaerobic respiratory pathways
of N. gonorrhoeae (54). AniA is an inducible nitrite reductase
(46) that is required for anaerobic growth (33) with nitrite as
an electron acceptor (39). NorB is a nitric oxide reductase that
is also required for oxygen-limited growth and has been shown
to play a key role in protection of cells against nitric oxide
toxicity (34). Ccp is a cytochrome c peroxidase that is expressed
only during anaerobic growth (42) and is responsible for pro-
tecting the gonococcus from hydrogen peroxide-mediated kill-
ing (61). The majority of the downregulated genes did not have
identified functions, as 43 of the 67 genes are hypotheticals. Of
the 24 genes with identified functions, 6 belong to the nuo
operon, which is an NADH dehydrogenase (ND-1) involved in
respiratory electron transfer (65). All genes in the nuo operon
(nuoA to nuoN) were found to be downregulated via microar-
ray, although the remaining eight genes met only a 1.5-fold
cutoff.
Validation of microarray results. To confirm our microarray
results, we performed SYBR Green qRT-PCR. We selected a
variety of highly up- and downregulated genes, including aniA,
ccp, norB, and a representative of the nuo operon, nuoF. In
addition, we selected some genes with changes that were below
our 2-fold cutoff (those that met a 1.5-fold cutoff). Relative
RNA quantities were determined by a standard curve, and all
values were normalized to the amount of OMP3 RNA in each
sample. Reactions were performed in triplicate, and each qRT-
PCR assay was performed a minimum of two times. Expression
profiles were validated for differentially regulated genes (ab-
solute change of 2.0-fold or greater) when results were consis-
tent for both assays and absolute change values were equiva-
lent to or greater than the corresponding microarray change
values.
Thirteen of 16 selected targets were validated via qRT-PCR
(Table 3). The three genes that did not meet our criteria for
validation are known or suspected to be phase variable, which
might account for their inconsistent qRT-PCR profiles. The
unverified genes included ngo0023 (encoding a periplasmic
binding protein of an ABC transporter), ngo0641 (modA13
methylase gene), and ngo0080 (opaB).
Expression profiles of highly differentially regulated genes
in biofilms grown over host cells. Microarray and qRT-PCR
results indicated that aniA, ccp, norB, and the nuo operon are
among the most highly differentially expressed genes between
biofilm and planktonic growth states. This observation and the
identified roles of aniA, ccp, and norB in anaerobic respiration
made them attractive candidates for further study. However,
before characterizing the roles of these genes in biofilms, and
in view of the fact that N. gonorrhoeae is an obligate human
pathogen (30), we elected to study the expression profiles of
these genes in biofilms grown over THCEC. We did not per-
form microarray studies for biofilms grown over THCEC in
order to avoid the problem of contaminating THCEC RNAs
that may have skewed the microarray results.
In order to study the expression profiles of aniA, ccp, norB,
and nuoF in biofilms over cells, we grew biofilms over THCEC
TABLE 3. qRT-PCR validation of microarray resultsa
Gene (KEGG accession no.) Genename
Fold
change in
array
assay
(biofilm/
planktonic
growth)
Fold change
by qRT-PCR
(biofilm/
planktonic
growth)
(mean  SD)
Upregulated genes meeting a
2.0-fold cutoff
NGO0641 modA13 2.3 1.4  0.2
NGO1769 ccp 2.6 6.6  1.6
NGO0070 opaB 2.8 1.7  1.3
NGO1275 norB 2.8 6.7  2.0
NGO1276 aniA 5.4 17.9  4.2
Upregulated gene not meeting
a 2.0-fold cutoff
NGO0452 fimT 1.8 1.3  0.3
Downregulated genes meeting
a 2.0-fold cutoff
NGO1746 nuoF 2.1 3.5  0.8
NGO0182 tatB 2.2 2.6  0.6
NGO0752 narL 2.4 3.1  0.6
NGO0023 5.1 1.3 0.3
Downregulated genes not
meeting a 2.0-fold cutoff
NGO0189 secD 1.5 2.6  1.3
NGO0190 secF 1.5 3.0  1.4
NGO0138 mucD 1.6 3.5  1.2
NGO0181 tatC 1.7 1.9  0.3
NGO0633 nifU 1.7 4.7  0.8
NGO0753 narX 1.9 2.5  0.3
a Genes shown in bold did not meet our criteria for validation.
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in flow cells for 48 h, confirmed the presence of a biofilm by
confocal microscopy, and collected the planktonic effluent as
described for the microarray studies. We collected duplicate
planktonic and biofilm RNA samples from two independent
experiments and used these RNAs as templates for qRT-PCR.
We compared aniA, ccp, norB, and nuoF qRT-PCR expression
profiles from this experiment to the qRT-PCR profiles for
biofilms on glass (Fig. 1).
We found that aniA, ccp, and norB were upregulated in
biofilms grown over THCEC, similar to their expression in
biofilms grown on glass. The nuoF gene was also downregu-
lated in biofilms over THCEC, similar to the case for biofilms
on glass. The similar expression of these genes in biofilms
grown over cells and glass warranted pursuit of the role of
anaerobic respiration in N. gonorrhoeae biofilms.
Characterization of the role of anaerobic metabolism genes
in biofilms over glass. Wild-type N. gonorrhoeae clinical strain
1291 and isogenic aniA::kan, ccp::kan, and norB::kan mutants
were assayed for the ability to form biofilms in flow cells over
glass. These mutants were transformed with pGFP for exami-
nation of biofilms via confocal microscopy (Fig. 2). We found
that there was no significant difference in the biomass of the
aniA::kan or ccp::kan mutant when either was compared to the
wild type. However, the aniA::kan and ccp::kan mutants did
have significantly smaller average thicknesses (P  0.001). The
norB::kan mutant had the most dramatic biofilm-deficient phe-
notype, with significantly less biomass and significantly smaller
average thicknesses than the wild type (P  0.001) (Fig. 3). To
confirm that the defect in biofilm formation was not due to a
defect in growth under the oxygen tension conditions present
in the medium in our biofilm system, we measured the dis-
solved oxygen content of medium entering and exiting the flow
chambers at 0, 24, and 48 h. We found that the oxygen con-
centration (150 to 200 mm Hg) was much higher than concen-
trations that are typically considered to be anaerobic or mi-
croaerophilic (5 to 27 mm Hg) (15, 43). When we performed
48-hour growth curves under similar oxygen tension condi-
tions, we found that there was no defect in the growth of
aniA::kan, norB::kan, and ccp::kan insertion mutants compared
FIG. 1. Relative RNA quantities were determined by a standard
curve, and all values were normalized to the amount of OMP3 RNA in
each sample. Reactions were performed in triplicate, and each qRT-
PCR assay was performed a minimum of two times. qRT-PCR values
for biofilms grown over THCEC are displayed by gray bars, and qRT-
PCR values for biofilms grown over glass are displayed by white bars.
The error bars represent 1 standard deviation from the mean for the
averaged qRT-PCR data from duplicate assays.
FIG. 2. Biofilm masses over 2 days of growth for wild-type N. gonorrhoeae strain 1291 (1) and aniA::kan (2), ccp::kan (3), and norB::kan (4)
insertion mutants. All four strains were visualized by GFP plasmid expression. The images are three-dimensional reconstructions of stacked z series
taken at a magnification of 200 and rendered by Volocity. These experiments were performed a minimum of three times, and representative
results are shown.
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to the wild type. This finding was the same for growth curves
conducted under aerobic culture conditions (data not shown).
Characterization of the role of anaerobic metabolism genes
in biofilms over THCEC. Wild-type N. gonorrhoeae clinical
strain 1291 and aniA::kan, ccp::kan, and norB::kan insertional
mutants were also assayed for the ability to form biofilms over
THCEC, as all three anaerobic mutants were deficient in some
aspect of biofilm formation over glass. We used confocal mi-
croscopy to evaluate whether the phenotypes of biofilms grown
on glass were similar to or more exaggerated than those of
biofilms grown over cells (Fig. 4). As the qRT-PCR results
suggested, based on at least equivalent expression of these
genes in biofilms grown over THCEC, these biofilms were
more severely attenuated over THCEC than on glass. All three
mutants had significantly less biomass and significantly smaller
average thicknesses than the wild type did (P  0.001) (Fig. 5).
Effect of nitric oxide on N. gonorrhoeae biofilm formation.
We observed that the norB mutant had a more pronounced
biofilm-deficient phenotype than an aniA mutant when N. gon-
orrhoeae biofilms were grown over glass. One explanation for
this phenotype is that NO accumulates in the norB mutant, and
not in the aniA mutant, since AniA produces NO and this
radical species is reduced by NorB to nitrous oxide. Findings
for Pseudomonas aeruginosa (2) and Staphylococcus aureus (52)
suggest that NO may be an important signaling molecule that
causes biofilm detachment when present at sublethal concen-
trations within the biofilm. This prompted us to investigate the
effect of NO on wild-type N. gonorrhoeae 1291 biofilms grown
FIG. 3. COMSTAT and statistical analyses of biomass (A) and average thickness (B) for wild-type (checkered bars) and aniA::kan (black bars),
ccp::kan (gray bars), and norB::kan (white bars) insertion mutant biofilms grown over glass for 2 days. Representative images of these biofilms are
depicted in Fig. 2. All strains were run in duplicate in a minimum of three experiments, and at least four images of each biofilm chamber were
used for COMSTAT analysis. The error bars represent 1 standard deviation from the mean. Statistical differences between mutants and the wild
type, determined by Student’s t test, are denoted by asterisks above the error bars. ***, P value of 0.001 or less.
FIG. 4. Biofilm masses over 2 days of growth for wild-type N. gonorrhoeae strain 1291 (1) and aniA::kan (2), ccp::kan (3), and norB::kan (4)
insertion mutants. All four strains were visualized by GFP plasmid expression, while THCEC were visualized by Cell Tracker Orange (Molecular
Probes, Invitrogen Corp., Carlsbad, CA) staining. The images are three-dimensional reconstructions of stacked z series taken at a magnification
of 200 and rendered by Volocity. These experiments were performed a minimum of three times, and representative results are shown.
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over glass. Wild-type biofilms treated with a sublethal concen-
tration of NO (500 nM) either at the start of the biofilm or
after 24 h of biofilm growth did have significantly less biomass
and smaller average thicknesses than untreated biofilms. There
was no apparent difference in biomass and average thickness
for biofilms grown for 24 h without treatment and biofilms
grown for 24 h and then treated with SNP for another 24 h.
This suggests that the addition of SNP to a 24-hour biofilm
halts development of the biofilm. Furthermore, biofilm forma-
tion was restored to wild-type levels when biofilms were simul-
taneously treated with NO and an NO quencher, suggesting
that defects in biofilm formation were due to the accumulation
of NO (Fig. 6). Treatment with the NO quencher (PTIO)
alone did not alter biofilm formation (data not shown).
In order to directly assess the effect of NO accumulation on
norB mutant biofilms, we also treated N. gonorrhoeae 1291
norB:kan biofilms with the NO quencher and compared these
biofilms to untreated norB:kan biofilms. We found that treat-
FIG. 5. COMSTAT and statistical analyses of biomass (A) and average thickness (B) for wild-type (checkered bars) and aniA::kan (black bars),
ccp::kan (gray bars), and norB::kan (white bars) insertion mutant biofilms grown over THCEC for 2 days. Representative images of these biofilms
are depicted in Fig. 4. All strains were run in duplicate in a minimum of three experiments, and at least four images of each biofilm chamber were
used for COMSTAT analysis. The error bars represent 1 standard deviation from the mean. Statistical differences between mutants and the wild
type, determined by Student’s t test, are denoted by asterisks above the error bars. *, P value of 0.05 or less; **, P value of 0.01 or less.
FIG. 6. (A) Biofilm masses over 2 days of growth for wild-type N. gonorrhoeae strain 1291, either untreated (1), treated with SNP at the start
of the biofilm (t 	 0) (2), grown as a biofilm for only 24 h and left untreated (3), treated with SNP after 24 h of biofilm growth (t 	 24 h) (4), or
treated simultaneously with SNP and PTIO (5). All biofilms were visualized by GFP plasmid expression. The images are three-dimensional
reconstructions of stacked z series taken at a magnification of 200 and rendered by Volocity. These experiments were performed a minimum of
four times, and representative results are shown. (B) Table showing results of COMSTAT analysis of biomass and average thickness. Statistical
differences between treated samples and the untreated control (48-h biofilm) were determined via paired Student’s t tests, and the corresponding
P values are listed.
3528 FALSETTA ET AL. INFECT. IMMUN.
ment with the NO quencher enhanced norB mutant biofilm
formation compared to untreated biofilm formation (Fig. 7).
Moreover, we found that a higher concentration of NO
quencher was required to restore the defect in biofilm forma-
tion by the norB mutant than that for wild-type biofilms arti-
ficially treated with an NO donor. This finding suggests that
NO accumulates at concentrations in excess of 500 nM in norB
mutant biofilms.
DISCUSSION
Microarray analysis indicated that biofilms of N. gonorrhoeae
possess a unique transcriptional profile distinguishing them
from planktonic modes of growth. Specifically, genes required
for anaerobic respiration (aniA, ccp, and norB) were more
highly expressed during biofilm growth, while genes involved in
respiration with NADH as an electron donor (nuo operon)
were more highly expressed during planktonic growth. Mutants
in which the aniA, ccp, or norB gene was interrupted by the
insertion of a kanamycin cassette were attenuated for biofilm
formation over glass and THCEC. Overall, these biofilms were
less cohesive, were structurally instable, and often contained
significantly less biomass or were thinner than wild-type bio-
films. N. gonorrhoeae is frequently isolated from the genitouri-
nary tract in the presence of obligate anaerobes (56), and AniA
is a major antigen recognized in sera from patients with gono-
coccal disease (12). Thus, anaerobic respiration probably oc-
curs naturally during infection, and since it also seems likely
that N. gonorrhoeae forms biofilms during cervical infection
(59), this suggests that biofilm formation is critical for success-
ful infection of the female genitourinary tract.
N. gonorrhoeae was initially considered incapable of anaer-
obic growth (35), despite being isolated in the presence of
obligate anaerobes (56). However, Short and coworkers dem-
onstrated that N. gonorrhoeae is capable of survival under an-
aerobic conditions (55). Knapp and Clark later determined
that anaerobic growth in N. gonorrhoeae is coupled to nitrite
reduction and that supplementation with nitrite is required for
growth under these conditions, explaining previous unsuccess-
ful attempts to grow the organism anaerobically (39). Overton
and coworkers went on to demonstrate that nitrous oxide is the
end product of nitrite reduction, indicating that N. gonorrhoeae
catalyzes partial denitrification, converting nitrite to nitrous
oxide via nitric oxide (48).
AniA (formerly called Pan 1) was identified in a screen for
anaerobically regulated genes, as one of three outer membrane
proteins whose expression is induced under anaerobic growth
conditions (11). Examination of sera from patients with com-
plicated or uncomplicated gonococcal infection indicated that
there is a strong antibody response to AniA, demonstrating
that AniA is expressed in vivo and thus that anaerobic growth
likely occurs during infection (12). AniA was later shown to be
a lipoprotein (29) that functions as a nitrite reductase (46) and
is subsequently required for anaerobic growth (33).
AniA is tightly regulated by oxygen availability and is virtu-
ally undetectable in aerobically cultured cells (33). Thus, ele-
vated AniA expression in biofilms is a strong indicator that
gonococcal biofilms grow anaerobically or microaerobically.
Isolation of N. gonorrhoeae in the presence of obligate anaer-
obes suggests that oxygen is limited in the female genitourinary
tract (56), and therefore biofilm formation may aid in the
ability to respire under conditions of oxygen limitation in the
host environment. With Neisseria meningitidis, Rock and Moir
have shown that the addition of nitrite significantly enhances
growth of this bacterium under oxygen-limited conditions (49),
and thus it is possible that a combination of (micro)aerobic
respiration and partial denitrification is optimal in gonococcal
biofilms. Furthermore, if AniA is capable of modulating the
immune response by binding complement regulatory proteins
that can downregulate the immune response, as suggested by
Cardinale and Clark (5), then biofilm growth may also convey
an advantage to growth by aiding in immune evasion.
NO, the product of nitrite reduction by AniA in N. gonor-
rhoeae, has been shown to be an important signaling molecule
and a modulator of cellular events (14, 41, 44, 47, 58, 60). Low
basal levels of NO (nM scale) have been determined to be
anti-inflammatory, while high levels of NO (M scale) have
been shown to be proinflammatory, stimulating the immune
response (4, 14, 58). NO is also known to be toxic to some
bacterial cells (14, 20, 44, 68) and is produced by nitric oxide
synthases of polymorphonuclear neutrophils (6, 20, 44, 45).
Thus, it has been postulated that NO production may be part
of the innate immune response to bacterial infection, although
this is currently a controversial topic (20).
NorB is a heme protein responsible for reducing AniA-
generated NO to nitrous oxide (34). Unlike most NO reduc-
tases that are found in denitrifying organisms (68), such as
Pseudomonas aeruginosa (1), NorB is composed of a single
functional subunit (34). N. gonorrhoeae is capable of establish-
ing a steady-state NO level during anaerobic growth and can
reduce NO concentrations of1 M (proinflammatory) in the
surrounding medium to approximately 100 nM (anti-inflam-
matory) in less than an hour (4). This suggests that N. gonor-
rhoeae is capable of rapidly reducing not only endogenously
produced NO generated during anaerobic respiration but also
environmentally produced NO from phagocytic cells. Cervical
FIG. 7. (A) Biofilm masses over 2 days of growth for N. gonor-
rhoeae strain 1291 norB::kan, either untreated (1) or treated with PTIO
(2). Biofilms were visualized by GFP plasmid expression. The images
are three-dimensional reconstructions of stacked z series taken at a
magnification of 200 and rendered by Volocity. These experiments
were performed a minimum of three times, and representative results
are shown. (B) Table showing results of COMSTAT analysis of bio-
mass and average thicknesses. Statistical differences between treated
samples and the untreated control were determined via paired Stu-
dent’s t tests, and the corresponding P values are listed.
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endothelial and epithelial cells have also been found to pro-
duce NO (40, 60), again implying that reduction of NO by the
gonococcus may be critical during infection. During cervical
infection, the gonococcus does not induce cytokine production
in the host, suggesting that the organism either fails to induce
the immune response or suppresses the response via an un-
known mechanism (27, 50). Additionally, only low levels of
antigonococcal antibody can be detected during uncompli-
cated infection in women (27), which cannot be attributed
completely to the antigenic and phase variation of many
surface-exposed gonococcal structures (30). The ability of
the gonococcus to rapidly reduce host-produced NO from
proinflammatory to anti-inflammatory levels may then help
to account for the lack of a strong immune response in
women with uncomplicated gonorrhea. Suppression of the
immune response would likely result in the inability to clear
the organism as well as in downregulation of the inflamma-
tory response, resulting in the absence of noticeable symp-
toms. Thus, biofilm formation may be a special adaptation
to growth in the cervical environment, enabling the gono-
coccus to persist in a chronic infection state.
N. gonorrhoeae is not the only organism that appears to
catalyze anaerobic respiration during biofilm growth. P. aerugi-
nosa, a well-studied biofilm-forming organism, has been shown
to undergo anaerobic respiration during growth as a biofilm,
and this is thought to be the primary mode of respiration
during cystic fibrosis infection (21, 26, 62, 66). P. aeruginosa has
been shown to form better biofilms under anaerobic than un-
der aerobic growth conditions, and mutants with insertions in
many of the anaerobic metabolism genes do not form biofilms
as well as the wild type does (66). A recent study of Moraxella
catarrhalis also determined that genes involved in anaerobic
metabolism are highly upregulated during biofilm formation
versus planktonic growth. Interestingly, M. catarrhalis is be-
lieved to be incapable of anaerobic growth. However, it is
suggested that the ability to reduce NO may aid in the survival
of M. catarrhalis in the nasopharynx (64). The observation that
other organisms catalyze anaerobic respiration during biofilm
growth suggests that biofilm formation could contribute to the
ability to respire under oxygen-limited conditions. Our obser-
vation that a norB mutant had a more pronounced biofilm-
deficient phenotype than an aniA mutant when biofilms were
grown over glass bears similarity to findings for P. aeruginosa.
In P. aeruginosa, a norBC (NO reductase) insertion mutant
forms virtually no biofilm under anaerobic growth conditions,
while a nir (nitrite reductase) mutant forms biofilms similar to
those of the wild type (66). One explanation for this observa-
tion could be that NO accumulates under anaerobic growth
conditions in the absence of an NO reductase, resulting in slow
growth or cell death. An alternative explanation is that NO is
an important signaling molecule in N. gonorrhoeae biofilms
that elicits biofilm dispersal, which has been shown to be true
for P. aeruginosa (2) and Staphylococcus aureus (52) biofilms.
Inherent antimicrobial resistance in biofilms results in the in-
ability to clear biofilm infection even with high doses of anti-
biotics (9, 16, 51), which makes biofilm dispersal an appealing
target for the treatment of biofilm infection. NO treatment has
been shown to augment the effects of antimicrobial treatment
of P. aeruginosa biofilms (2). In agreement with these results,
we found that treatment of N. gonorrhoeae biofilms with an NO
donor either at the start of the biofilm or after 24 h of biofilm
growth either hindered biofilm formation or elicited biofilm
dispersal. Furthermore, addition of an NO quencher to norB
mutant biofilms enhanced biofilm formation, suggesting that
NO accumulation accounts for the severe biofilm-deficient
phenotype observed with this mutant. We considered the pos-
sibility that production of NO in the norB::kan mutant could
result in a growth defect by inhibition of cytochrome oxidase,
subsequently impairing aerobic respiration. However, it has
been shown that cytochrome cbb3 of Pseudomonas stutzeri, an
isoenzyme in the family of cytochrome c oxidases, actually
possesses nitric oxide reductase capability (23). The nitric ox-
ide reductase activity of cytochrome cbb3, although consider-
ably lower than the nitric oxide reductase activity in P. stutzeri,
is the highest within the heme-copper oxidase superfamily
(23). Furthermore, the norB::kan mutant showed no growth
defect when grown under oxygen tension conditions that mimic
those present in the medium of our biofilm apparatus, and
cytochrome cbb3 is the only oxidase present in N. gonorrhoeae.
Cytochrome c peroxide, encoded by ccp, is a lipoprotein and
is the sixth c-type cytochrome induced during anaerobic
growth (61). Transcription of ccp is controlled by the fumarate
and nitrate reductase regulator protein, which controls the
expression of other important anaerobic metabolism genes in
N. gonorrhoeae, such as aniA (42). Ccp plays an important role
in oxidative stress defense by reducing hydrogen peroxide
(H2O2) to water (H2O) (53). H2O2 is produced by polymor-
phonuclear neutrophils (6) and Lactobacillus species present in
the female genitourinary tract (19). Specifically, H2O2-produc-
ing Lactobacillus strains are capable of inhibiting the growth of
N. gonorrhoeae by acidification of the medium, H2O2 toxicity,
and production of protein inhibitors (57, 67). Thus, upregula-
tion of ccp during biofilm formation by N. gonorrhoeae may
represent a critical adaptation for survival in the female geni-
tourinary tract.
It is established from studies of the closely related mitochon-
drial complex 1 that NADH dehydrogenases of this type are
highly susceptible to inactivation by nitric oxide, peroxynitrite,
and S-nitrosothiols (3). The lower level of expression of nuo in
biofilms suggests that the gonococcus is also able to alter ex-
pression of primary dehydrogenases in the respiratory chain.
Biofilm formation by the gonococcus may aid in oxidative
stress tolerance during host infection by positively regulating
factors, such as ccp and norB, which are required for the
reduction of reactive oxygen and nitrogen species, respectively.
Overall, anaerobic growth may be an important mechanism by
which the gonococcus copes with the inherent oxidative
stresses that are present during infection of human cervical
tissues.
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